Business Context and Reporting Period
This Form 8-K, dated January 6, 2026, reports on a special meeting of shareholders held by Fifth Third Bancorp regarding its proposed acquisition of Comerica Incorporated. The filing details the voting results on matters necessary to proceed with the merger under the Agreement and Plan of Merger dated October 5, 2025.
Key Financial Metrics
This filing is a current report on corporate governance and shareholder voting; it does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics for Fifth Third Bancorp or Comerica.
Material Changes and Voting Results
Shareholders approved two critical proposals to facilitate the merger:
- Proposal 1 (Stock Issuance): Approved the issuance of Fifth Third common stock as merger consideration. This issuance exceeds 20% of currently outstanding shares, requiring shareholder approval under NASDAQ Rule 5635(d).
- Votes For: 536,814,002
- Votes Against: 1,088,494
- Abstentions: 378,950
- Proposal 2 (Adjournment): Approved the authority to adjourn the meeting if necessary to solicit additional proxies.
- Votes For: 497,437,700
- Votes Against: 40,320,977
- Abstentions: 522,769
Attendance: A quorum was established with 80.84% of the voting power present (536,090,267 common shares and 3,651,965 depositary shares of voting preferred stock).
Guidance, Outlook, and Risks
The filing contains standard forward-looking statements regarding the merger's completion and future benefits. Key risks and contingencies identified include:
- Regulatory Approval: The transaction is contingent upon obtaining necessary regulatory approvals and satisfying closing conditions.
- Transaction Failure: Risks of failure to complete the merger or unexpected delays.
- Adverse Conditions: Potential regulatory conditions imposed that could adversely affect the combined company or expected synergies.
Management disclaims any obligation to update forward-looking statements.
Investor Verification Checklist
- Verify the status of regulatory approvals required to close the Comerica acquisition.
- Review the Joint Proxy Statement/Prospectus (dated November 25, 2025) for detailed merger terms and financial projections.
- Monitor subsequent filings for updates on the closing timeline and any conditions imposed by regulators.
- Confirm the final share exchange ratio and any adjustments to the merger consideration.